Estimaciones de analistas de Wall Street para Oncolytics Biotech Inc. (ONCY): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.07 | ||
| 2026-08-12 | $-0.08 | $-0.05 | -48.7% |
| 2026-05-14 | $-0.08 | $-0.05 | -60.0% |
| 2026-03-30 | $-0.01 | $-0.06 | +83.1% |
| 2025-11-12 | $-0.10 | $-0.12 | +16.7% |
| 2025-08-08 | $-0.05 | $-0.11 | +54.5% |
| 2025-05-14 | $-0.06 | $-0.09 | +33.3% |
| 2025-03-07 | $-0.07 | $-0.08 | +12.5% |
Ratios de valoración
| Precio / Valor contable | -20.69 |
| EV / EBITDA | -2.98 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $162233 | $90768 | $95375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$162233 | -$90768 | -$95375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $9.8M | $9.4M | $9.4M | $10.8M | $12.9M | $12.9M | $11.4M | $13.3M | $15.4M | $13.3M |
| Generales y Administrativos | $5.4M | $6.2M | $7.2M | $9.3M | $12.5M | $12.9M | $8.2M | $11.8M | $10.1M | $15.4M |
| Gastos Operativos | $15.3M | $15.6M | $16.7M | $20.1M | $25.5M | $26.2M | $19.8M | $25.5M | $25.5M | $28.7M |
| Beneficio Operativo | -$15.3M | -$15.6M | -$16.7M | -$20.1M | -$25.5M | -$26.2M | -$19.8M | -$25.5M | -$25.5M | -$28.7M |
| EBITDA | -$13.8M | -$15.3M | -$17.2M | -$19.7M | -$25.4M | -$25.8M | -$19.5M | -$25.2M | -$25.5M | -$28.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.1M | -$15.5M | -$16.5M | -$33.1M | -$22.5M | -$26.3M | -$18.2M | -$20.8M | -$22.7M | -$28.7M |
| Impuestos | $9374 | $141498 | $548042 | 0 | 0 | $49000 | $61892 | $73119 | $95000 | $79000 |
| Beneficio Neto | -$15.1M | -$15.6M | -$17.0M | -$45.6M | -$22.5M | -$26.3M | -$18.3M | -$20.9M | -$22.8M | -$28.8M |
| BPA | $-1.20 | $-1.12 | $-1.06 | $-1.50 | $-0.48 | $-0.49 | $-0.44 | $-0.41 | $-0.30 | $-0.41 |
| BPA Diluido | $-1.20 | $-1.12 | $-1.06 | $-1.50 | $-0.48 | $-0.49 | $-0.44 | $-0.41 | $-0.30 | $-0.41 |
| Acciones en Circulación (Diluidas) | $12.6M | $13.9M | $16.0M | $22.1M | $40.3M | $53.5M | $58.0M | $67.6M | $76.5M | $95.9M |
Precio
| Precio | $0.77 |
| Capitalización | $77M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ATOS · CLNN · COYA · IMMX · MGNX · SRZN · TIL
Explorar sector: Healthcare · Biotechnology
Más secciones de ONCY: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones